Ilan Zipkin is the Vice President, Business Development, at the Parker Institute for Cancer Immunotherapy. Ilan is responsible for leading Parker Institute’s collaboration and partnering activities with academic institutions, biotechnology and pharmaceutical companies. He brings more than 16 years of life science venture capital experience, including institutional and corporate venture investing, company management and board of director roles. His focus is on the intersection of biology and business, and the translation of basic discoveries into drug development. A San Francisco native, Ilan received a PhD in cell biology from UCSF before moving into business via a stint as writer and Science Editor for BioCentury Publications. He enjoys scuba diving and musical theater with his wife Cori and his children, and balances all the seriousness with an avid comic book collection.